Loading...

By MBN Staff - Mon, 11/10/2025 - 11:12

Lilly partners with the US government to expand access to obesity drugs, reinforcing its long-term commitment to healthcare affordability.

Partnership Content

https://mexicobusiness.news/tag/zepbound

More Health

By Sofía Garduño - Tue, 02/18/2025 - 13:42

A new survey shows GLP-1 medication access is increasingly important for job retention and hiring, with demand driving employer-sponsored coverage.

By MBN Staff - Thu, 08/08/2024 - 17:41

Lilly and Novo Nordisk compete in the weight-loss market amid significant supply shortages. Analysts forecast a 50-50 market split by late 2024.

By MBN Staff - Tue, 08/06/2024 - 09:47

Lilly predicts the Mounjaro shortage will soon end as global demand for obesity drugs grows.